Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy.
Francesca NegosantiVera TengattiniCarlotta GurioliIria NeriPublished in: Journal of cosmetic dermatology (2018)
We report the case of a 40-year-old female affected by tuberous sclerosis, whose facial angiofibromas were satisfactorily treated by rapamycin 0.05% ointment, and a combined laser therapy.
Keyphrases